Summary. Early corpus luteum development in nonpregnant and pregnant goats was characterized by a steady increase in peripheral plasma concentrations of progesterone and a high release of prostacyclin (PGI-2) but low release of prostaglandin F-2\g=a\ (PGF2\g=a\).Jugular administration of oxytocin antagonist (OXA) (0\m=.\2\g=m\g/kg/day) on the day of oestrus and for 3 days thereafter to cyclic and mated goats, significantly (P < 0\m=.\001) inhibited progesterone and prostaglandin secretion and reduced conception rate. Co\ x=req-\ administration of PGI-2 (200 \g=m\g/day) with OXA resulted in a steady increase of progesterone and establishment of pregnancy, but co-administration of (175 \g=m\g/day) with OXA had no effect. It is suggested that oxytocin is required for early development of the corpus luteum and such effects may be mediated via PGI-2 production.
Introduction
Recent investigations have shown that oxytocin is secreted in substantial amounts by the corpus luteum (CL) in several species (Flint & Sheldrick, 1982; Wathes & Swann, 1982; Fields et al., 1983; Kahn-Dawood & Dawood, 1983; Wathes et ai, 1983; Kahn-Dawood et al., 1984; Homeida, 1986a) . Oxytocin could be involved in regulating luteal regression either directly by a local action on the corpus luteum as in monkeys (Auletta et al., 1984) or indirectly by inducing the release of prostaglandin F-2a , the uterine luteolysin (Horton & Poyser, 1976) in animals such as goat (Cooke & Knifton, 1981; Cooke & Homeida, 1982 and sheep (Fairclough et ai, 1984) .
Several other prostanoids are produced by the uterus in response to oxytocin stimulation (Hansel & Dowd, 1986) . For example, the myometrium synthesizes prostacyclin (PGI-2) in a greater amount than (Alwachi et ai, 1980) . PGI-2 is a luteotrophic agent (Hansel & Dowd, 1986) and is maximally produced by bovine luteal cells early in the oestrous cycle (Milvae & Hansel, 1983 ), the only time at which high doses of oxytocin are effective in inhibiting luteal func¬ tion (Armstrong & Hansel, 1959; Cooke & Knifton, 1981; Cooke & Homeida, 1982) . However, oxytocin at low doses can stimulate progesterone production by human and bovine luteal cells in vitro (Tan et ai, 1982a, b) . In this study, an oxytocin antagonist (OXA), which inhibited luteal regression in goats (Homeida & Khalafalla, 1987 , was administered at the beginning of the oestrous cycle in goats, to investigate the role of oxytocin on early development of the corpus luteum and on prostaglandin (PG) production.
Materials and Methods
Animals. Thirty-two mature Awassi goats (2-4 years old and with normal oestrous cycle of 19-20 days) were housed in pens under natural daylength and temperature. Animals were synchronized with two 5 mg injections of a PGF-2a analogue (Lutalyse: Upjohn Ltd, Crawley, UK) given 11 days apart. When the goats exhibited oestrus (determined by a fertile buck), they were randomly divided into eight groups.
Treatments. In group A, four goats were injected (i.v.) daily with saline (0-9% w/v NaCl) on the day of oestrus (Day 0) and for 3 days thereafter. In group B, four goats were mated to a fertile buck and treated with saline as for group A. In group C, six goats were treated as for group A, but with oxytocin antagonist (OXA) (l-(B-mercapto-B, Bdiethylpropionic acid), 2-0-ethyltyrosine, 8-ornithino) vasotocin (dEt2 Tyr (Et)-OVT, Code KB-IV-24) (a gift from Professor M. Manning) dissolved in saline and given i.v. at 0-2 µg/kg body weight (Homeida & Khalafalla, 1990) . In group D, six goats were mated to a fertile buck and treated as for group C. In group E, three goats were treated with OXA, but, in addition, 200 pg PGI-2 sodium salt (Upjohn Co., Kalamazoo, ML, USA) in 1 ml saline was injected i.v. This dose produced^2ng 6 keto-PGF-la/ml in plasma and reduced spontaneous uterine activity (Cooke & Homeida, 1989 Radioimmunoassay of hormones. Plasma progesterone was measured by the radioimmunoassay (RIA) method described by Homeida (1986b) , Homeida et ai (1988) and Homeida & Khalafalla (1990) . Progesterone antibody (provided by Dr H. Dobson) was raised in rabbits against progesterone-11-succinyl-bovine serum albumin, and used at a final dilution of 1:7000; cross-reactions were 100% with progesterone and <0-l% with corticosterone, desoxycorticosterone and ketocorticosterone.
The intra-and interassay coefficients of variation (CV) for progesterone were 41 (n = 25) and 111% (n = 20), respectively, for a plasma sample of low progesterone concentration (0-8 ng) and 4-2 (« = 25) and 11-6% (n = 20), respectively, for a plasma of high concentration (5 ng). The sensitivity of the assay was 48 pg/tube. Extraction efficiency was 85-4 ± 5-2 (s.d.)% and the results were corrected for extraction losses.
PGFM was extracted from plasma with diethyl ether and assayed as described by Cooke & Homeida (1985) . The antibody (Upjohn, Kalamazoo, MI, USA) was used at a final dilution of 1:1000 and cross-reactions (relative to PGFM = 100%) were: 15-keto-PGF-2a, 7-5%; 13,14-dihydro-PGF-2a, 0-7% PGE-2, 0-5%, and PGF-2a <001%. The sensitivity of the assay was 45 pg/ml. The intra-and interassay coefficients of variation were 8-0% («=11) and 11-5% (n= 11), respectively, for a sample with a low concentration of PGFM (100 pg/ml) and 81 (n = 11) and 11-1% («= 10), respectively, for a sample with a high concentration (800 pg/ml). Extraction efficiency was 84-3 ±7-2 (s.d.)% and results were corrected for extraction losses.
A specific RIA for 6-keto-PGF-la in homogenates of sheep uterus was used as described by Liggins el ai (1980) and validated by Cooke & Homeida (1989) using an antiserum (4V-208) at a dilution of 1:10000. Standard curves were constructed using pure 6-keto-PGF-la (Upjohn). The recovery of added tracer was 710 + 5% (mean + s.e.m., = 9) and results were corrected for extraction losses; the recovery of standards (20, 50, 500, 1000 pg) added to goat plasma was 19-4+ 1-6, 51-6 + 6-8, 489-0 ± 141 and 8930 ± 171 pg (mean ± s.e.m., « = 6). The non-specific binding was 8%, the sensitivity of the assay 10 pg/tube, and the intra-and interassay coefficients of variation were 61 and 121%, respectively (n= 12). Antiserum specificity has been reported previously (Liggins et ai, 1980 full pregnancy and kidded after 147 days. Oxytocin antagonist significantly (P < 001) reduced the conception rate from 100% to 16% (group vs. group D).
Goats in groups E and G (PGI-2 administered with OXA) behaved similarly to those in groups A and B, respectively (Table 1) . Animals in groups F and H (PGF-2a with OXA) behaved similarly to animals in groups C and D, respectively.
Increasing concentrations of progesterone, high concentrations of 6-keto-PGF-la and low con¬ centrations of PGFM were observed in animals of groups A and (Fig. 1) The concentrations of PGs (during an 8 h period) were estimated in pooled samples collected daily in animals of groups A and and compared during the early development of the CL. Concen¬ trations of 6-keto-PGF-la were significantly (P < 0001) higher than those of PGFM (Fig. 2) ratios of 6-keto-PGF-la:PGFM on Days 0, 1, 2, 3 and 4 were, respectively, 2-5, 5, 6, 5 and 6 after oestrus and 3, 6, 7, 6 and 7 after mating.
Discussion
The development of a functional CL in both cyclic (group A) and pregnant (group B, mated, later confirmed to be pregnant) goats was evident on Day 2 after oestrus; plasma progesterone concen¬ tration being > 1 ng/ml (Homeida & Cooke, 1982) . The administration of OXA to these animals completely inhibited progesterone secretion, shortened the oestrous cycle and reduced the concep¬ tion rate. Similar effects on the CL of the cycle and pregnancy have been produced by indomethacin treatment in cattle (Milvae & Hansel, 1985) and active immunization against oxytocin in sheep (Wathes et al., 1989) , respectively. These observations suggest that agonistic actions of oxytocin may be required for early development of the CL, since such actions were blocked by OXA. OXA has been shown to be a potent antagonist to oxytocin in a rat uterus bioassay and a study of milk ejection response (Bankowski et al., 1980) and PGF-2a and testosterone secretion in rats and goats (Chan et al., 1982; Homeida & Khalafalla, 1987 . The origin of this oxytocin could be the follicle, the young CL (Wathes, 1984) or the pituitary gland (Mitchell et al., 1982) . Furthermore, high oestrogen production or mating at oestrus would provoke the release of oxytocin (Ferguson, 1941; Blank & Debias, 1977; Wathes, 1984) .
The results also show that development of the CL was accompanied by release of PGs, mainly PGI-2, suggesting a luteotrophic effect of this PG around oestrus in the goat (Milvae & Hansel, 1980 Hansel & Convey, 1983; Hansel & Dowd, 1986) . Differential release of the PGs (PGI-2 and PGF-2a) may be explained by the fact that a substance may alter enzymic conversion of intermediates in prostaglandin biosynthesis (Alwachi et al., 1980; Silvia et al., 1984) , that PGF-2a and PGI-2 are derived from a common endoperoxide intermediate (Hamberg & Samuelsson, 1973; Alwachi et al., 1980) and that driving synthesis towards one product therefore reduces concen¬ trations of the other. The origin of PGI-2 may be the uterus or corpus luteum (Milvae & Hansel, 1983) . It was demonstrated that the rat uterus and sheep endometrium can produce PGI-2 at 10 times the rate of PGF-2a (Fenwick et al., 1977; Alwachi et al., 1980) and that an increase in the ratio of concentration of luteotrophic to luteolytic PGs during the critical stages of CL develop¬ ment, rather than the concentration of individual PGs, may be significant in luteotrophic events (Balmaceda et al., 1979; Patwardhan & Lanthier, 1980) . However, unlike the present study, these authors estimated the ratio of the amounts of different PGs produced by homogenates, which may not reflect the output of the PGs by the intact tissue (Poyser, 1985) .
OXA was very effective in inhibiting both PGF-2a (Homeida & Khalafalla, 1987) and PGI-2 production, thus removing the luteotrophic effects of PGI-2 on the CL. Furthermore, the finding that treatment with indomethacin, the PG-synthesizing inhibitor, during the early bovine oestrous cycle inhibited development of the CL and lowered plasma progesterone (Milvae & Hansel, 1985) confirms that a prostaglandin of uterine origin is important as a luteotrophin.
To investigate further the luteotrophic effects of PGI-2, the drug was administered with OXA. A functional CL developed, suggesting that the effect of oxytocin on CL development is likely to be produced via PGI-2 production. However, other PGs, such as prostaglandin E-l can produce similar effects to PGI-2, possibly because they act through the same receptors in some tissues (Abramowitz & Brinbaumer, 1979) . It is proposed that uterine production of PGs in ewes is regu¬ lated by progesterone and oestrogens (Vallet et al., 1990) which induce uterine oxytocin receptors and that oxytocin binding to these receptors stimulates phospholipase A2, the arachidonic acid cascade and production of PGs (McCracken et al., 1984; Bazer et al., 1986) . The administration of PGF-2a with OXA had no effect.
It has been demonstrated that active immunization against oxytocin reduces the conception rate in ewes (Wathes et al., 1989) , suggesting that the effect may be mediated via interference with gamete or embryo transport. Our results confirm these findings using OXA and suggest that oxy¬ tocin may be implicated in gonadotrophin secretion (Homeida & Cooke, 1989) , ovulation (Mitchell et al., 1980) , conception (Wathes et al., 1989) and early development of a functional CL.
